CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the Age of COVID-19” series co-hosted by CAACB and BioMAN. The summary presents a snapshot of information drawn from expert presentations and a pre-workshop survey of consortia members, covering topics such as…
Category: CAACB
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating biopharmaceutical manufacturing processes. Read the complete publication HERE. Read the MIT News piece HERE. Story: Ann Trafton, MIT News Office| Image: Betsy Skrip, CBI
Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020
In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is coping with COVID-19. These informal meetings will be a place where industry experts will share their organization’s response to the unique challenges now facing biomanufacturing operations. These meetings are open to…
The Bioprocessing Summit Interview with Paul Barone
Cambridge Healthtech Institute recently spoke with Dr. Paul Barone of Massachusetts Institute of Technology about Viral Safety and where the field and industry is headed in coming years. Dr. Barone is a speaker at the 3rd Annual Virus and Pathogen Clearance and Safety in Biologics which is taking place from August 24-25, 2017 in Boston,…